Literature DB >> 8287060

Radioiodinated L-703,606: a potent, selective antagonist to the human NK1 receptor.

B E Francis1, C Swain, V Sabin, H D Burns.   

Abstract

A new, radioiodinated, NK1 selective radiotracer ([125I]L-703,606) was prepared. L-703,606 is an iodinated analog of the NK1 antagonist CP-96,345 in which the methoxy group has been replaced by an iodine substituent. [125I]L-703,606 was made from the corresponding trimethylsilyl compound by treatment with no carrier added Na 125I and an Iodobead in TFA. The tracer was prepared at a specific activity of approx. 1100 Ci/mmol and preliminary binding studies demonstrated that [125I]L-703,606 binds selectively to NK1 receptors with a kd = 0.3 nM. These results suggest that this radioligand will be useful for the biochemical and pharmacological characterization of the human NK1 receptor and, if labeled with I-123, may be useful for non-invasive NK1 receptor imaging via SPECT.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8287060     DOI: 10.1016/0969-8043(94)90154-6

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN: 0969-8043            Impact factor:   1.513


  2 in total

1.  Development of a High-throughput NanoBRET Screening Platform to Identify Modulators of the RAS/RAF Interaction.

Authors:  David E Durrant; Emily A Smith; Ekaterina I Goncharova; Nirmala Sharma; Patrick A Alexander; Andrew G Stephen; Curtis J Henrich; Deborah K Morrison
Journal:  Mol Cancer Ther       Date:  2021-06-22       Impact factor: 6.009

2.  First evaluation of [11C]R116301 as an in vivo tracer of NK1 receptors in man.

Authors:  Saskia P A Wolfensberger; Bart N M van Berckel; Anu J Airaksinen; Kaoru Maruyama; Mark Lubberink; Ronald Boellaard; William D H Carey; Wieb Reddingius; Dick J Veltman; Albert D Windhorst; Josée E Leysen; Adriaan A Lammertsma
Journal:  Mol Imaging Biol       Date:  2009-03-31       Impact factor: 3.488

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.